PLX4032

PLX4032 Struktur
918504-65-1
CAS-Nr.
918504-65-1
Englisch Name:
PLX4032
Synonyma:
R7204;104532;CS-1916;Vemurafenib, >=99%;PLX4032 (VeMurafenib);Zelboraf (vemurafenib);(1029872-54-5) vemurafenib;Vemurafenib (10mM in DMSO);Vemurafenib (RG7204,PLX4032);VeMurafenib (PLX4032, RG7204)
CBNumber:
CB02550000
Summenformel:
C23H18ClF2N3O3S
Molgewicht:
489.92
MOL-Datei:
918504-65-1.mol

PLX4032 Eigenschaften

Dichte
1.46
storage temp. 
-20°C
Löslichkeit
Soluble in DMSO (up to 100 mg/ml)
Aggregatzustand
White powder.
pka
6.26±0.10(Predicted)
Farbe
White or off-white
Stabilität:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
CAS Datenbank
918504-65-1
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
HS Code  29339900
Giftige Stoffe Daten 918504-65-1(Hazardous Substances Data)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H410 Sehr giftig für Wasserorganismen mit langfristiger Wirkung. Langfristig (chronisch) gewässergefährdend Kategorie 1 Warnung GHS hazard pictogramssrc="/GHS09.jpg" width="20" height="20" /> P273, P391, P501
Sicherheit
P273 Freisetzung in die Umwelt vermeiden.
P391 Verschüttete Mengen aufnehmen.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

PLX4032 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

In August 2011, the United States FDA approved vemurafenib (PLX- 4032, RO-5185426) for the treatment of patients with metastatic melanoma with the BRAFV600E mutation. Vemurafenib has been developed as a targeted therapy for patients with the BRAF gene mutation since oncogenic B-raf signaling is implicated in approximately 50% of melanomas. Vemurafenib was identified based on an initial high-throughput screen followed by the extensive use of structure-based drug design. Vemurafenib is a potent inhibitor of B-RafV600E kinase (IC50=13 nM) compared to its potency against wildtype B-raf (IC50=160 nM) and is fairly selective versus a panel of 200 kinases. It does inhibit other kinases (RAF1, SRMS, ACK1, MAP4K5, and FGR) and mutant B-raf kinases (BRAFV600K, BRAFV600D, and BRAFV600R) with enzyme IC50's of <100 nM.

Chemische Eigenschaften

Off-White Solid

Verwenden

Vemurafenib selective BRAFV600E kinase inhibitor; an antitumor agent. Vemurafenib functions by inhibiting the proliferation and mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase and ERK phosphorylation in a panel of tumor cell lines, including melanoma cell lines expressing BRAFV600E or other mutant BRAF proteins altered at codon 600.

Definition

ChEBI: A pyrrolopyridine that is 1H-pyrrolo[2,3-b]pyridine which is substituted at position 5 by a p-chlorophenyl group and at positions 3 by a 3-amino-2,6-difluorobenzoyl group, the amino group of which has undergone ormal condensation with propane-1-sulfonic acid to give the corresponding sulfonamide. An inhibitor of BRAF and other kinases.

PLX4032 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


PLX4032 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 246)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32480 60
Shandonghaohong biotechnology Co.,ltd.
0635-6175299 13961496334
sale@inyelchem.com CHINA 44 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Shanghai Arbor Chemical Co., Ltd.
021-60451682
act@arborchemical.com CHINA 906 58
Accela ChemBio Inc.
(+1)-858-699-3322
info@accelachem.com United States 19965 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58

  • N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaMide
  • PLX4032 (VeMurafenib)
  • PLX4032, RG7204, ZELBORAF, RO5185426
  • R7204
  • N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaM
  • PLX4032, R7204, RG7204, RO5185426
  • VeMurafenib (PLX4032, RG7204)
  • N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide Vemurafenib PLX 4032
  • Zelboraf (vemurafenib)
  • Vemurafenib, >=99%
  • Vemurafenib (RG7204,PLX4032)
  • RG7204;PLX-4032;PLX 4032;RG-7204
  • CS-1916
  • PLX 4032 - RG 7204 | Vemurafenib | RO 5185426
  • 104532
  • (1029872-54-5) vemurafenib
  • N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaMide USP/EP/BP
  • Vemurafenib (10mM in DMSO)
  • VemurafenibQ: What is Vemurafenib Q: What is the CAS Number of Vemurafenib Q: What is the storage condition of Vemurafenib Q: What are the applications of Vemurafenib
  • Raf kinases,Vemurafenib,inhibit,PLX 4032,Inhibitor,RO-5185426,RG 7204,Raf,Autophagy,RG-7204,RO 5185426,PLX-4032
  • 918504-65-1
  • API
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Protein Kinase Inhibitors and Activators
  • Sulfur & Selenium Compounds
  • Inhibitor
  • RG7204
  • Antineoplastic
  • MAPK
  • Inhibitors
  • Aromatics
Copyright 2019 © ChemicalBook. All rights reserved